Astrana Health (NASDAQ:ASTH) Price Target Increased to $67.00 by Analysts at Robert W. Baird

Astrana Health (NASDAQ:ASTH) had its price target boosted by Robert W. Baird from $54.00 to $67.00 in a research report report published on Thursday, Benzinga reports. They currently have an outperform rating on the stock.

Other research analysts also recently issued reports about the stock. Truist Financial increased their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a buy rating in a research report on Friday, August 9th. Stifel Nicolaus lifted their target price on shares of Astrana Health from $48.00 to $60.00 and gave the stock a buy rating in a research note on Thursday, August 1st. Finally, Baird R W upgraded Astrana Health to a strong-buy rating in a research note on Thursday, May 30th. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of Buy and a consensus target price of $59.00.

Astrana Health Stock Performance

Shares of ASTH opened at $48.23 on Thursday. The company has a market cap of $2.70 billion, a price-to-earnings ratio of 36.54, a P/E/G ratio of 1.83 and a beta of 1.16. Astrana Health has a 52 week low of $28.86 and a 52 week high of $54.27. The business’s 50 day moving average is $44.93. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.52 and a quick ratio of 1.52.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. The business had revenue of $486.30 million during the quarter, compared to analyst estimates of $440.68 million. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. Astrana Health’s quarterly revenue was up 39.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.28 EPS. On average, equities analysts forecast that Astrana Health will post 1.42 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.